Depressive DisorderNCT06668701
Evaluation of the Naturalistic User Experience of the Website "Ich Bin Alles"
An observational study of Depressive Disorder and Depression, run by Ludwig-Maximilians - University of Munich at 1 site in Germany.
Trial summary
Using a multi-method approach, the aim of this study is to investigate the naturalistic user experience and acceptance of the German website "ich bin alles". This website offers evidence-based information about the symptoms, causes, course, treatment, and prevention of youth depression. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Depressive Disorder, Depression, Depression in Children
- What is being tested?
- "ich bin alles"
- Type of treatment
- Medical device
- How many people
- 494 participants
- Where
- 1 siteGermany
- Study dates
- 20 Jun 2024to 1 Apr 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: users of the website "ich bin alles"
Who may be able to join
- 40 seconds website-use
Who cannot join
- no exclusion criteria
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of the Naturalistic User Experience of the Website "Ich Bin Alles" - an Information Platform for Children and Adolescents With and Without Depression and Their Relatives
Using a multi-method approach, the aim of this study is to investigate the naturalistic user experience and acceptance of the German website "ich bin alles". This website offers evidence-based information about the symptoms, causes, course, treatment, and prevention of youth depression. Another aim of this study is to determine whether the desired target groups of the website can be reached.
Read the detailed description
Depressive disorders are among the most common mental illnesses in children and adolescents and were already on the rise before the COVID-19 pandemic. This trend has been further exacerbated by the pandemic. Depression in adolescents is associated with particularly serious consequences, such as school and social problems, increased risk of suicide and impaired mental health in adulthood. If depression persists, the risk of chronification increases and continuous school attendance or continuation of vocational training is more difficult. The longer a depressive illness is not (effectively) treated, the lower the likelihood of remission and the higher the risk of chronification with further depressive episodes over the course of the illness. Although there are effective forms of treatment, in Germany only around 12% of adolescents with increased symptoms of depression seek professional treatment. The main barriers for adolescents to seek professional help include, for example, individual factors (low knowledge of mental disorders), social factors (e.g., perceived social stigmatisation) and systemic and structural barriers (e.g., limited access to professional help). In order to meet the need for action in a timely manner that meets the needs of the target group, the Department of Child and Adolescent Psychiatry of the Hospital of the LMU Munich and the Beisheim Foundation launched the innovative digital information portal "ich bin alles" ("I am everything"; www.ich-bin-alles.de) on depression and mental health in youth in 2021. Due to a sharp increase in online health information in recent years, the quality of this information and information portals has increasingly become the centre of attention. A review of the quality of mental health information websites found that many of the websites had shortcomings in terms of transparency, presentation and accuracy of content. These limitations were confirmed in a more recent study of depression websites. The comprehensibility of the content is also often limited, especially for users with a lower level of education and/or health literacy.
Due to the high relevance of comprehensively evaluating web-based information services on mental health and mental illness, the aim of this study is to use established methods to learn more about the visitors of "ich bin alles" and their user experience. This study will build on the approach of previous studies on website evaluation, which usually follow a multi-method approach: The evaluation of website analyses using tools such as Matomo; as well as an online questionnaire. The study is intended to provide clues as to whether the "ich bin alles" information platform is a useful and trustworthy source of information for the target groups. The information obtained is of central importance for potential adaptations and optimizations of the "ich bin alles" website. Another aim of this study is to determine whether "ich bin alles" can actually reach its desired target groups. The results of the data collection also provide an important basis for future approaches aimed at informing children, young people and their parents about mental health issues and mental illness in a way that is appropriate for the target group.
- Being tested
- "ich bin alles"
- Keywords
- depression, prevention, web-based, adolescents, depression literacy, user experience, acceptance
- Medical subject headings
- Depressive Disorder, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
"ich bin alles"Device
The web-based information platform "ich bin alles" (www-ich-bin-alles.de) on depression and mental health in childhood and adolescence was developed by the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy of the LMU Munich Hospital together with the Prof. Otto Beisheim Foundation. It is aimed at children and adolescents with depression, healthy children and adolescents and parents. The project focuses on education, prevention, support and destigmatisation through the transfer of evidence-based knowledge.
What is being measured
The primary outcome is the main question the study is designed to answer.
The characteristics of the people who are interested in "ich bin alles" (i.e. the users) - Assessed via self-designed questionnaire
Measured: post (40 seconds after Website-use)
Perception of the users of website content - Assessed via WEB-CLIC-S
Measured: post (40 seconds after Website-use)
Perceived Website Usability - Assessed via Perceived Website Usability - German
Measured: post (40 seconds after Website-use)
Visual Aesthetics of Website - Assessed via Visual Aesthetics of Website Inventory - Short
Measured: post (40 seconds after Website-use)
Overall impression - assessed via a single item (school grade)
Measured: post (40 seconds after Website-use)
Intentions to act - Assessed via Scale assessing the intention to revisit the website
Measured: post (40 seconds after Website-use)
Secondary outcomes (5)
specific data collected for "ich bin alles" with Matomo
Title of the pages accessed (page title)
Measured: 45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Location of the users: Country, region, city, approximate latitude and longitude (geolocation)
Measured: 45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Number of the website users
Measured: 45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
How the users accessed the website (e.g. Google search or Social Media link)
Measured: 45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
How much time the users spend on the website
Measured: 45 months (from launch of the website until anticipated study completion)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Oct 2024
- Study start20 Jun 2024
- Primary completion1 Apr 2026
- Study completion1 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Depressive DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 494 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Sponsor type
- University, hospital or other
- Collaborators
- Prof. Otto Beisheim Foundation
- Responsible party
- Principal investigator, Ellen Greimel, LMU Klinikum
- Investigators
- Gerd Schulte-Körne, Prof. Dr., Study director, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, LMU University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06668701
- Sponsor's protocol ID
- 24-0201 KB
- Status last verified
- Sep 2026
- First submitted
- 27 Sep 2024
- Last updated
- 21 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Naturalistic User Experience of the Website "Ich Bin Alles" - an Information Platform for Children and Adolescents With and Without Depression and Their Relatives
- ClinicalTrials.gov ID
- NCT06668701
- Acronym / sponsor ID
- 24-0201 KB
- Keywords
- depression, prevention, web-based, adolescents, depression literacy, user experience, acceptance
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 494 participants (actual)
- Lead sponsor
- Ludwig-Maximilians - University of MunichUniversity, hospital or other
- Collaborators
- Prof. Otto Beisheim Foundation
- Study start
- 20 Jun 2024 (actual)
- Primary completion
- 1 Apr 2026 (actual)
- Study completion
- 1 Apr 2026 (actual)
- First posted
- 31 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Using a multi-method approach, the aim of this study is to investigate the naturalistic user experience and acceptance of the German website "ich bin alles". This website offers evidence-based information about the symptoms, causes, course, treatment, and prevention of youth depression. Another aim of this study is to determine whether the desired target groups of the website can be reached.
Detailed description
Depressive disorders are among the most common mental illnesses in children and adolescents and were already on the rise before the COVID-19 pandemic. This trend has been further exacerbated by the pandemic. Depression in adolescents is associated with particularly serious consequences, such as school and social problems, increased risk of suicide and impaired mental health in adulthood. If depression persists, the risk of chronification increases and continuous school attendance or continuation of vocational training is more difficult. The longer a depressive illness is not (effectively) treated, the lower the likelihood of remission and the higher the risk of chronification with further depressive episodes over the course of the illness. Although there are effective forms of treatment, in Germany only around 12% of adolescents with increased symptoms of depression seek professional treatment. The main barriers for adolescents to seek professional help include, for example, individual factors (low knowledge of mental disorders), social factors (e.g., perceived social stigmatisation) and systemic and structural barriers (e.g., limited access to professional help). In order to meet the need for action in a timely manner that meets the needs of the target group, the Department of Child and Adolescent Psychiatry of the Hospital of the LMU Munich and the Beisheim Foundation launched the innovative digital information portal "ich bin alles" ("I am everything"; www.ich-bin-alles.de) on depression and mental health in youth in 2021. Due to a sharp increase in online health information in recent years, the quality of this information and information portals has increasingly become the centre of attention. A review of the quality of mental health information websites found that many of the websites had shortcomings in terms of transparency, presentation and accuracy of content. These limitations were confirmed in a more recent study of depression websites. The comprehensibility of the content is also often limited, especially for users with a lower level of education and/or health literacy.
Due to the high relevance of comprehensively evaluating web-based information services on mental health and mental illness, the aim of this study is to use established methods to learn more about the visitors of "ich bin alles" and their user experience. This study will build on the approach of previous studies on website evaluation, which usually follow a multi-method approach: The evaluation of website analyses using tools such as Matomo; as well as an online questionnaire. The study is intended to provide clues as to whether the "ich bin alles" information platform is a useful and trustworthy source of information for the target groups. The information obtained is of central importance for potential adaptations and optimizations of the "ich bin alles" website. Another aim of this study is to determine whether "ich bin alles" can actually reach its desired target groups. The results of the data collection also provide an important basis for future approaches aimed at informing children, young people and their parents about mental health issues and mental illness in a way that is appropriate for the target group.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- users of the website "ich bin alles"
Key inclusion criteria (1 listed)
- 40 seconds website-use
Key exclusion criteria (1 listed)
- no exclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| "ich bin alles"The web-based information platform "ich bin alles" (www-ich-bin-alles.de) on depression and mental health in childhood and adolescence was developed by the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy of the LMU Munich Hospital together with the Prof. Otto Beisheim Foundation. It is aimed at children and adolescents with depression, healthy children and adolescents and parents. The project focuses on education, prevention, support and destigmatisation through the transfer of evidence-based knowledge. | Device | – |
Primary outcome
The characteristics of the people who are interested in "ich bin alles" (i.e. the users) - Assessed via self-designed questionnaire
Time frame: post (40 seconds after Website-use)
Perception of the users of website content - Assessed via WEB-CLIC-S
Time frame: post (40 seconds after Website-use)
Perceived Website Usability - Assessed via Perceived Website Usability - German
Time frame: post (40 seconds after Website-use)
Visual Aesthetics of Website - Assessed via Visual Aesthetics of Website Inventory - Short
Time frame: post (40 seconds after Website-use)
Overall impression - assessed via a single item (school grade)
Time frame: post (40 seconds after Website-use)
Intentions to act - Assessed via Scale assessing the intention to revisit the website
Time frame: post (40 seconds after Website-use)
5 secondary outcomes
specific data collected for "ich bin alles" with Matomo
Time frame: 45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Time frame: 45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Time frame: 45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Time frame: 45 months (from launch of the website until anticipated study completion)
specific data collected for "ich bin alles" with Matomo
Time frame: 45 months (from launch of the website until anticipated study completion)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Sep 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Depressive Disorder
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Recruiting
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gerd Schulte-Körne, Prof. Dr. study director
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, LMU University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Depressive Disorder and Depression, run by Ludwig-Maximilians - University of Munich at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The characteristics of the people who are interested in "ich bin alles" (i.e. the users) - Assessed via self-designed questionnaire (time frame: post (40 seconds after Website-use)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.